Greg Rubin,1 Nafees Din,2 Richard Neal,2 William Hamilton3

Slides:



Advertisements
Similar presentations
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Advertisements

TEMPLATE DESIGN © Overview: Management Of Ovarian Cancer in Primary Care (1)Fabian Lee, Foundation Year 2. (2) Gbolahan.
Detecting Cancer earlier in Tower Hamlets – The New Network Service Dr. Tania Anastasiadis Tower Hamlets GP Cancer Lead & GP Macmillan facilitator The.
School for Primary Care Research Increasing the evidence base for primary care practice The School for Primary Care Research is a partnership between the.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Effect of Reduction in Use of Computed Tomography for Appendicitis Bachur RG, Levy.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.
Department of General Practice Aarhus University Diagnostic delay in cancer in primary health care Before and after introducing urgent referrals for suspected.
Greg Rubin Professor of General Practice and Primary Care University of Durham.
Colorectal Pathway North Bristol NHS Trust. Background Colorectal pathway introduced in 2006 Shorten patient pathway Straight to test Reduce routes into.
Risk of colorectal cancer in patients taking statins and NSAIDS Dr Yana Vinogradova, Prof Julia Hippisley-Cox, Dr Carol Coupland and Prof Richard Logan.
Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms, signs and tests in relation to colorectal cancer Olde Bekkink.
MARK COLEMAN MBChB FRCS (Gen Surg) MD hon FRCPSG Consultant Colorectal Surgeon
Endoscopy Matters NICE guidance dyspepsia, New build, National Context & NAEDI Dr Michelle Gallagher Consultant Gastroenterologist.
Improving Cancer Outcomes in Camden Dr Lucia Grun 15 October 2014.
Flexible Sigmoidoscopy And Whole Colon Imaging In The Diagnosis Of Cancer In Patients With Colorectal Symptoms Peter O’Leary Journal Club 13/10/08.
The Symptom Study Overview Cohort study with nested qualitative study Set in 2 University centres: Cambridge & Durham Aim to recruit 200 cases with each.
Aetiology of preoperative anaemia in patients undergoing elective cardiac surgery Jacob Abhrahm 1,Romi Sinha 2,Kathryn Robinson 3, David Cardone 1 1 Department.
Diagnostic Intervals in Breast, Colorectal, Lung, Pancreatic, Oesophageal and Gastric Cancers and : Database Study Richard D NealBangor.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
FIT Programme (Faecal Immunohistochemical Test)
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
West Yorkshire R & D Cancer and palliative care workshop
The capacity challenge:
CRC 101; Part One Julie Banahan, RN, BSN, OCN
The English experience of promoting dementia recognition and management in primary care Alzheimer’s New Zealand/ADI Conference November 3rd-5th 016 Steve.
San Antonio Breast Cancer Symposium, December 6-10, 2016
Cancer Audit Stourport Health Centre Feb 2016
CRC 101; Part One Julie Banahan, RN, BSN, OCN
Improving access through Innovation
Quality of Electronic Emergency Department Data: How Good Are They?
Colorectal Cancer: Risk Prevention and Diagnosis
Dr Daniel Anderson Consultant psychiatrist
Participants 18year old+
CRL 6MM Is transvaginal ultrasound a reliable test in the diagnosis of early embryonic demise? Outcomes of embryos of less than 6mm in crown-rump length.
Table 1: Patient Demographics
Rebecca Greenawaya and Lorna Fortuneb
Syndrome of Inappropriate Antidiuretic Hormone (SIADH) in Lung Cancer 12 months experience from a Cancer Unit Bulusu V R, Jessop S, Jeffs Y P, Thomas.
Cancer Diagnosis in the Acute Setting (CaDiAS)
(2) - Department of Epidemiology and Population Health, and
Presenting with IBS symptoms, baseline assessment.
Cascade of care for persons newly diagnosed
(95% confidence interval)
Segmented analysis of prostate cancer pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Dr James Carlton, Medical Adviser
Ageing with ideal cardiovascular risk factors
Presenter: Wen-Ching Lan Date: 2018/08/01
Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
National Cancer Diagnosis Audit
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Seasonal variation of incidence
The Research Question Aim TIA is defined by short-lasting symptoms
Colorectal Cancer Cancer Alliance Work
Cystic Neoplasm of the Pancreas Clinical Review of 60 Cases and Treatment Strategy D.K.Kim, S.I.Noh, J.S.Heo, J.H.Noh, T.S.Sohn, S.J.Kim, S.H.Choi, J.W.Joh,
(95% confidence interval)
Clinical features of bowel disease in patients aged
Clinical features of bowel disease in patients aged
The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review by Margaret Astin, Tom Griffin, Richard D Neal, Peter Rose,
More Than One-Third of Women in the U. S. Skip Care Because of Cost vs
Clinical features of bladder cancer in primary care
Dr Constantinos Koshiaris
CRL 6MM Is transvaginal ultrasound a reliable test in the diagnosis of early embryonic demise? Outcomes of embryos of less than 6mm in crown-rump length.
Breath Testing for Gastrointestinal Disease
FIT for symptomatic patients
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway
D94- COPD: EPIDEMIOLOGY AND THERAPY
Suspected Gynaecological Cancer Recognition & Referral
Colorectal 2 week wait pathways and “Getting FIT”
Faecal Immunochemistry Test - qFIT
Presentation transcript:

Greg Rubin,1 Nafees Din,2 Richard Neal,2 William Hamilton3 Diagnostic Intervals in Colorectal Cancer 2001-02 and 2007-08: Database Study Greg Rubin,1 Nafees Din,2 Richard Neal,2 William Hamilton3 1-School of Medicine and Health, Durham University 2-North Wales Centre for Primary Care Research, North Wales Clinical School, Bangor University 3-Peninsula College of Medicine and Dentistry, University of Exeter Background Results Results Fig. 3: Overlaid histograms showing distribution of diagnostic intervals in Cohort 1 & 2 up to a year before the date of diagnosis. The arrow head shows the shift of diagnostic intervals from 2001-02 to 2007-08. Shorter ‘Diagnostic Intervals’, the crucial period between the first presentation of potential cancer symptoms, usually to primary care, and diagnosis, may lead to earlier stage diagnoses and better cancer outcomes. The General Practice Research Database (GPRD) in the UK is a well-validated dataset for research in primary care. As part of the National Awareness and Early Diagnosis Initiative (NAEDI), we undertook a GPRD study. Fig. 1a & 1b: First presentation of any cancer symptom: There was a reduction of around 25% (21 days) in median diagnostic interval from 2001-02 to 2007-08. This difference was statistically significant (below left). Despite this, both cohorts had long diagnostic intervals towards the third and fourth quartiles as presented in the 90th centile graph (below right) and overlaid histograms of the two cohorts in Fig. 3 (opposite right). Aims To determine and compare diagnostic intervals in two time periods (2001-02 & 2007-08), before and after the introduction of the 2005 NICE Referral Guidelines for Suspected Cancer; and to create baselines for future comparisons. Conclusions Median diagnostic intervals significantly reduced between 2001-02 and 2007-08. The 90th centile diagnostic intervals also reduced but less so. Both remained relatively high in 2007-08 (median 75 days, 90th centile 279 days) suggesting that there remains considerable room and potential for improvement. Patients with an initial non-NICE qualifying symptom, followed by a NICE qualifying symptom had the shortest diagnostic intervals, followed by those with an initial NICE symptom, followed by those with no NICE qualifying symptoms; the diagnostic intervals for all three groups fell between the two cohorts but they were significant for the NICE category. The difference between the 2001-02 cohort and the 2007-08 cohort was that patients with a diagnostic interval of 3-8 months were ‘shifted’ to one of 1-4 months. There was little effect on the important tail of the distribution. The beneficial effect of this shift on stage at diagnosis remains unknown. Between the two cohorts there was a major policy initiative; that of implementation of the 2005 Referral Guidelines for Suspected Cancer; whilst the study was not designed to be causal, we can hypothesise that the changes between the two cohorts were in part due to this. Methods Dataset: Newly diagnosed cancer patients aged ≥ 40 with at least one year of complete medical records before diagnosis. Patient cohorts: Symptomatic patients diagnosed between: 01/01/2001-31/12/2002 inclusive (Cohort 1 n= 1825) 01/01/2007-31/12/2008 inclusive (Cohort 2 n= 2716) Patients who did not present with symptoms were excluded. Symptom identification: Symptoms included were anaemia, anorexia, fatigue, weight loss, abdominal pain, change in bowel habit, constipation, diarrhoea and rectal bleeding. NICE qualifying symptoms: Symptoms were categorised into ‘NICE qualifying and non-qualifying’ based on the review of guidelines, literature and current practice. Diagnostic interval: The duration in days from first presentation of cancer related symptom(s) in primary care to date of diagnosis. Data analysis: Diagnostic intervals in the two cohorts were compared and are presented here for: First symptomatic presentation (Fig. 1) NICE qualifying symptoms, divided into three groups (Fig. 2): Initial presentation of a NICE qualifying symptom (‘always NICE’) Initial presentation of a NICE non-qualifying symptom, followed by a NICE qualifying symptom prior to diagnosis (‘became NICE’) No NICE qualifying symptoms prior to diagnosis (‘never NICE’) Fig. 2: Diagnostic intervals by NICE categories: There was a reduction in diagnostic intervals for all the categories of NICE symptoms but this was more pronounced and significant for NICE qualifying category. Greg Rubin: g.p.rubin@durham.ac.uk Nafees Din: dinnu@cardiff.ac.uk Richard Neal: nealrd@cardiff.ac.uk William Hamilton: Willie.hamilton@pms.ac.uk Contact Conflicts of interest: The authors declare that there are no conflicts of interest in this study. Acknowledgements: This research was funded by the National Cancer Action Team and the Department of Health Cancer Policy Team. The views contained are those of the authors and do not represent Department of Health Policy. We thank Sally Stapley for her help in data manipulation.